trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid
CAS: 49708-81-8
Ref. TR-C379455
| 1g | 141.00 € | ||
| 500mg | 94.00 € | ||
| 2500mg | 195.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid
Controlled Product
Synonyms:
- Cyclohexanecarboxylic acid
- 4-(4-chlorophenyl)-
- trans-
- trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid
- trans-4-(p-Chlorophenyl)cyclohexanecarboxylic acid
- trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid
- (1R,4R)-4-(4-Chlorophenyl)Cyclohexanecarboxylic Acid
- (E)-4-(4-Chlorophenyl)cyclohexanecarboxylic acid
- Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)-, trans-
Description:
Applications trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid is an impurity of Atovaquone (A793500), which is a hydroxynaphthoquinone derivative that inhibits mitochondrial electron transport and possess antipneumocystic activity.
References Hudson, A.T., et al.: Drugs Exp. Clin. Res., 17, 427 (1991), Fry, M., et al.: Biochem. Pharmacol., 43, 1545 (1992), El-Sadr, W.M., et al.: N. Engl. J. Med., 339, 1889 (1998),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
238.71
Formula:
C13H15ClO2
Color/Form:
Neat
InChI:
InChI=1S/C13H15ClO2/c14-12-7-5-10(6-8-12)9-1-3-11(4-2-9)13(15)16/h5-9,11H,1-4H2,(H,15,16)/t9-,11-
InChI key:
InChIKey=NXXDIEYTMQYWJU-HOMQSWHASA-N
SMILES:
O=C(O)[C@H]1CC[C@H](c2ccc(Cl)cc2)CC1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-C379455 trans-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
